19th Ave New York, NY 95822, USA

Grupo de Oncología Molecular

El Grupo de Oncología Molecular del VHIO aplica las tecnologías más avanzadas basadas en tejidos a la investigación básica, traslacional y clínica, con un claro enfoque hacia el desarrollo y la validación de nuevos biomarcadores tumorales para la medicina de precisión en oncología.

Junto con el Grupo de Genómica del Cáncer y el Grupo de Oncology Data Science (ODysSey) del VHIO, participamos en nuestro Programa de Preselección Molecular interno. En nuestra Unidad de Investigación en Terapia Molecular del Cáncer (UITM) – CaixaResearch, perfilamos molecularmente a más de 1500 pacientes al año como candidatos a participar en ensayos clínicos de fase inicial.

Nuestro grupo también es una de las plataformas tecnológicas centrales del VHIO y, por tanto, nuestro laboratorio es clave para las líneas y los programas de investigación traslacional del VHIO. Participamos activamente en todos los proyectos que implican el uso de tejidos humanos recogidos de pacientes, incluidos los análisis de biomarcadores para la estratificación de pacientes y su inclusión en ensayos clínicos, la patología digital, los bancos de tejidos y el desarrollo de modelos primarios de xenoinjertos derivados del paciente (PDX).

Nuestro equipo también sigue trabajando tanto de forma independiente como en colaboración para establecer el impacto del microbioma en el desarrollo y la progresión del cáncer colorrectal. En particular, hemos desarrollado un ensayo de diagnóstico de Fusobacterium nucleatum que permite la visualización y la cuantificación simultáneas de las bacterias intratumorales. Con este ensayo identificamos por primera vez el Fusobacterium nucleatum como biomarcador de la recaída en el cáncer de recto(Annals of Oncology 2020). También lideramos el FUSOMAP, un proyecto de tres años financiado por la Fundación Mutua Madrileña y el Instituto de Salud Carlos III (ISCIII), para desarrollar modelos de diagnóstico y pronóstico basados en la microbiota mediante el mapeo de Fusobacterium intratumoral y la microbiota intestinal asociada en el cáncer colorrectal en fase inicial.

Paolo G. Nuciforo
Jefe de grupo
  • Descubrir y validar nuevos biomarcadores mediante tecnologías basadas en tejidos.
  • Identificar alteraciones seleccionables como parte del Programa de Preselección Molecular del VHIO.
  • Aplicar estrategias de patología molecular para respaldar los programas de desarrollo clínico precoz de fármacos.
  • Resolver la interacción espacial de la microbiota asociada al tumor, las células tumorales y las células inmunitarias en el microambiente tumoral.
  • Inmunohistoquímica multiplexada y análisis de imagen digital para análisis de alta resolución de la contextura de biomarcadores unicelulares y tisulares.
  • Definir mejor la epidemiología de las dianas moleculares para hacer aumentar la precisión de las estrategias de tratamiento.
  • Actuar como laboratorio central y local en los ensayos clínicos.
  • Servir como instalación central para los programas de investigación del VHIO.

Figura: A) Flujo de trabajo de KiQuant. B) Un núcleo tumoral teñido secuencialmente con Ki67 (arriba) y panqueratina (centro). Las dos tinciones se alinean en una única imagen digital virtual (abajo). La región tumoral de interés se identifica automáticamente por las áreas marrones positivas a la panqueratina (línea naranja punteada). Las células verdes y rojas representan los núcleos negativos y positivos en Ki67, respectivamente.

Jefe de grupo
Paolo G. Nuciforo
Médicas adjuntas
Roberta Fasani
Sara Simonetti
Siarhei Mauchanski
Supervisor de laboratorio
Jose Antonio Jiménez
Asistente de laboratorio
Mª Ángeles Diaz
Becaria postdoctoral
Francisca Gallego
Estudiantes de doctorado
Garazi Serna
Stefania Napoli
Técnicos
Lidia Alonso
Eloy Garcia
Xavier Guardia
Paola Martinez
Lidia Sánchez
Gertrudis Sánchez
César Sevillano
Margarita Gonzalez
Estudiante
Inés Terrones

Publicaciones científicas más relevantes

  • Borgognone A, Serna G, Noguera-Julian M, Alonso L, Parera M, Català-Moll F, Sanchez L, Fasani R, Paredes R, Nuciforo P. Performance of 16S Metagenomic Profiling in Formalin-Fixed Paraffin-Embedded versus Fresh-Frozen Colorectal Cancer Tissues. Cancers (Basel). 2021 Oct 29;13(21):5421.
  • Griguolo G, Serna G, Pascual T, Fasani R, Guardia X, Chic N, Paré L, Pernas S, Muñoz M, Oliveira M, Vidal M, Llombart-Cussac A, Cortés J, Galván P, Bermejo B, Martínez N, López R, Morales S, Garau I, Manso L, Alarcón J, Martínez E, Villagrasa P, Prat A, Nuciforo P. Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer. NPJ Precis Oncol. 2021 Mar 19;5(1):23.
  • Oliva M, Mulet-Margalef N, Ochoa-De-Olza M, Napoli S, Mas J, Laquente B, Alemany L, Duell EJ, Nuciforo P, Moreno V. Tumor-Associated Microbiome: Where Do We Stand? Int J Mol Sci. 2021 Feb 1;22(3):1446.
  • Cribiù FM, Erra R, Pugni L, Rubio-Perez C, Alonso L, Simonetti S, Croci GA, Serna G, Ronchi A, Pietrasanta C, Lunghi G, Fagnani AM, Piñana M, Matter M, Tzankov A, Terracciano L, Anton A, Ferrazzi E, Ferrero S, Iurlaro E, Seoane J, Nuciforo P. Severe SARS-CoV-2 placenta infection can impact neonatal outcome in the absence of vertical transmission. J Clin Invest. 2021 Mar 15;131(6):e145427.
  • Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer. Griguolo G, Serna G, Pascual T, Fasani R, Guardia X, Chic N, Paré L, Pernas S, Muñoz M, Oliveira M, Vidal M, Llombart-Cussac A, Cortés J, Galván P, Bermejo B, Martínez N, López R, Morales S, Garau I, Manso L, Alarcón J, Martínez E, Villagrasa P, Prat A, Nuciforo P.NPJ Precis Oncol. 2021 Mar 19;5(1):23. doi: 10.1038/s41698-021-00163-6.
  • Severe SARS-CoV-2 placenta infection can impact neonatal outcome in the absence of vertical transmission. Cribiù FM, Erra R, Pugni L, Rubio-Perez C, Alonso L, Simonetti S, Croci GA, Serna G, Ronchi A, Pietrasanta C, Lunghi G, Fagnani AM, Piñana M, Matter M, Tzankov A, Terracciano L, Anton A, Ferrazzi E, Ferrero S, Iurlaro E, Seoane J, Nuciforo P.J Clin Invest. 2021 Mar 15;131(6):e145427. doi: 10.1172/JCI145427.
  • Serna G, Ruiz-Pace F, Hernando J, Alonso L, Fasani R, Landolfi S, Comas R, Jimenez J, Elez E, Bullman S, Tabernero J, Capdevila J, Dienstmann R, Nuciforo P. Fusobacterium nucleatum persistence and risk of recurrence after preoperative treatment in locally advanced rectal cancer. Ann Oncol. 2020 Oct;31(10):1366-1375.
  • Serna G, Simonetti S, Fasani R, Pagliuca F, Guardia X, Gallego P, Jimenez J, Peg V, Saura C, Eppenberger-Castori S, Ramon Y Cajal S, Terracciano L, Nuciforo P. Sequential immunohistochemistry and virtual image reconstruction using a single slide for quantitative KI67 measurement in breast cancer. Breast. 2020 Oct;53:102-110.
  • Dienstmann R, Garralda E, Aguilar S, Sala G, Viaplana C, Ruiz-Pace F, González- Zorelle J, Grazia LoGiacco D, Ogbah Z, Ramos Masdeu L, Mancuso F, Fasani R, Jimenez J, Martinez P, Oaknin A, Saura C, Oliveira M, Balmaña J, Carles J, Macarulla T, Elez E, Alsina M, Braña I, Felip E, Tabernero J, Rodon J, Nuciforo P, Vivancos A. Evolving Landscape of Molecular Prescreening Strategies for Oncology Early Clinical Trials. JCO Precis Oncol. 2020 May 14;4:PO.19.00398.
  • Capdevila J, Mayor R, Mancuso FM, Iglesias C, Caratú G, Matos I, Zafón C, Hernando J, Petit A, Nuciforo P, Cameselle-Teijeiro JM, Álvarez CV, Recio JA, Tabernero J, Matias-Guiu X, Vivancos A, Seoane J. Early evolutionary divergence between papillary and anaplastic thyroid cancers. Ann Oncol. 2019 Nov 1;30(11):1843.
  • Vivancos A, Élez E, Salazar R. Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemoradiotherapy before surgery in patients with locally advanced rectal cancer: is it ready for primetime? Ann Oncol.29: 532-534.
  • Capdevila J,Mayor R; Mancuso FF, Iglesias C; Caratù G, Matos I, Zafón C, Hernando J, Petit A, Nuciforo P, Cameselle-Teijeiro JM, Álvarez C, Recio JA, Tabernero J, Matias-Guiu X, Vivancos A, Seoane J. Early evolutionary divergence between papillary and anaplastic thyroid cancers. Ann Oncol.29: 1454-1460.
  • Cedrés S, Felip E, Cruz C, Martinez de Castro A, Pardo N, Navarro A, Martinez-Marti A, Remon J, Zeron-Medina J, Balmaña J, Llop-Guevara A, Miquel JM, Sansano I, Nuciforo P,Mancuso F, Serra V, Vivancos A. Activity of HSP90 Inhibiton in a Metastatic Lung Cancer Patient With a Germline BRCA1 Mutation. J Natl Cancer Inst.110: 914-917.
  • Puig I, Tenbaum SP, Chicote I, Arqués O,Martínez-Quintanilla J, Cuesta-Borrás E, Ramírez L, Gonzalo P, Soto A, Aguilar S, Eguizabal C, Caratù G, Prat A, Argilés G, Landolfi S, Casanovas O, Serra V, Villanueva A, Arroyo AG, Terracciano L, Nuciforo P,Seoane J,Recio JA, Vivancos A,Dienstmann R,Tabernero J,Palmer HG.TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence. J Clin Invest.128: 3887-3905.
  • Cruz C, Castroviejo-Bermejo M, Gutiérrez-Enríquez S,Llop-Guevara A, Ibrahim YH, Gris-Oliver A, Bonache S, Morancho B, Bruna A, Rueda OM, Lai Z, Polanska UM, Jones GN; Kristel P, de Bustos L, Guzman M,Rodriguez O, Grueso J, Montalban G, Caratú G,Mancuso F, Fasani R, Jiménez J, Howat WJ, Dougherty B, Vivancos A, Nuciforo P, Serres-Créixams X, Rubio IT, Oaknin A, Cadogan E, Barrett JC, Caldas C, Baselga J, Saura C, Cortés J, Arribas J, Jonkers J, Díez O; O’Connor MJ, Balmaña J,Serra V. RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer. Ann Oncol.29: 1203-1210. IF: 13,926
  • Martínez-Ricarte F, Mayor R, Martínez-Sáez E, Rubio-Pérez C, Pineda E, Cordero E, Cicuéndez M, Poca MA, Lopez-Bigas N, Ramón Y Cajal S, Vieito M, Carles J, Tabernero J,Vivancos A, Gallego S, Graus F, Sahuquillo J, Seoane J. Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid.Clin Cancer Res.24: 2812-2819.

Todas las publicaciones

  • Oliva M, Mulet-Margalef N, Ochoa-De-Olza M, Napoli S, Mas J, Laquente B, Alemany L, Duell EJ, Nuciforo P, Moreno V. Tumor-Associated Microbiome: Where Do We Stand? Int J Mol Sci. 2021 Feb 1;22(3):1446.
  • Rubio-Perez C, Planas-Rigol E, Trincado JL, Bonfill-Teixidor E, Arias A, Marchese D, Moutinho C, Serna G, Pedrosa L, Iurlaro R, Martínez-Ricarte F, Escudero L, Cordero E, Cicuendez M, Ruiz S, Parra G, Nuciforo P, Gonzalez J, Pineda E, Sahuquillo J, Tabernero J, Heyn H, Seoane J. Immune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironment. Nat Commun. 2021 Mar 8;12(1):1503.
  • Cribiù FM, Erra R, Pugni L, Rubio-Perez C, Alonso L, Simonetti S, Croci GA, Serna G, Ronchi A, Pietrasanta C, Lunghi G, Fagnani AM, Piñana M, Matter M, Tzankov A, Terracciano L, Anton A, Ferrazzi E, Ferrero S, Iurlaro E, Seoane J, Nuciforo P. Severe SARS-CoV-2 placenta infection can impact neonatal outcome in the absence of vertical transmissionJ Clin Invest. 2021 Mar 15;131(6):e145427.
  • Griguolo G, Serna G, Pascual T, Fasani R, Guardia X, Chic N, Paré L, Pernas S, Muñoz M, Oliveira M, Vidal M, Llombart-Cussac A, Cortés J, Galván P, Bermejo B, Martínez N, López R, Morales S, Garau I, Manso L, Alarcón J, Martínez E, Villagrasa P, Prat A, Nuciforo P. Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer. NPJ Precis Oncol. 2021 Mar 19;5(1):23.
  • Chic N, Luen SJ, Nuciforo P, Salgado R, Fumagalli D, Hilbers F, Wang Y, de Azambuja E, Làng I, Di Cosimo S, Saura C, Huober J, Prat A, Loi S. Tumor Cellularity and Infiltrating Lymphocytes (CelTIL) as a Survival Surrogate in HER2-Positive Breast Cancer. J Natl Cancer Inst. 2021 Mar 31:djab057.
  • Gris-Oliver A, Ibrahim YH, Rivas MA, García-García C, Sánchez-Guixé M, Ruiz-Pace F, Viaplana C, Pérez-García JM, Llombart-Cussac A, Grueso J, Parés M, Guzmán M, Rodríguez O, Anton P, Cozar P, Calvo MT, Bruna A, Arribas J, Caldas C, Dienstmann R, Nuciforo P, Oliveira M, Cortés J, Serra V. PI3K activation promotes resistance to eribulin in HER2-negative breast cancer. Br J Cancer. 2021 Apr;124(9):1581-1591.
  • Frigola J, Navarro A, Carbonell C, Callejo A, Iranzo P, Cedrés S, Martinez-Marti A, Pardo N, Saoudi-Gonzalez N, Martinez D, Jimenez J, Sansano I, Mancuso FM, Nuciforo P, Montuenga LM, Sánchez-Cespedes M, Prat A, Vivancos A, Felip E, Amat R. Molecular profiling of long-term responders to immune checkpoint inhibitors in advanced non-small cell lung cancer. Mol Oncol. 2021 Apr;15(4):887-900.
  • Ligero M, Garcia-Ruiz A, Viaplana C, Villacampa G, Raciti MV, Landa J, Matos I, Martin-Liberal J, Ochoa-de-Olza M, Hierro C, Mateo J, Gonzalez M, Morales-Barrera R, Suarez C, Rodon J, Elez E, Braña I, Muñoz-Couselo E, Oaknin A, Fasani R, Nuciforo P, Gil D, Rubio-Perez C, Seoane J, Felip E, Escobar M, Tabernero J, Carles J, Dienstmann R, Garralda E, Perez-Lopez R. A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors. Radiology. 2021 Apr;299(1):109-119.
  • De Mattos-Arruda L, Cortes J, Blanco-Heredia J, Tiezzi DG, Villacampa G, Gonçalves-Ribeiro S, Paré L, Souza CA, Ortega V, Sammut SJ, Cusco P, Fasani R, Chin SF, Perez-Garcia J, Dienstmann R, Nuciforo P, Villagrasa P, Rubio IT, Prat A, Caldas C. The temporal mutational and immune tumour microenvironment remodelling of HER2-negative primary breast cancers. NPJ Breast Cancer. 2021 Jun 7;7(1):73
  • Ringborg U, Berns A, Celis JE, Heitor M, Tabernero J, Schüz J, Baumann M, Henrique R, Aapro M, Basu P, Beets-Tan R, Besse B, Cardoso F, Carneiro F, van den Eede G, Eggermont A, Fröhling S, Galbraith S, Garralda E, Hanahan D, Hofmarcher T, Jönsson B, Kallioniemi O, Kásler M, Kondorosi E, Korbel J, Lacombe D, Carlos Machado J, Martin-Moreno JM, Meunier F, Nagy P, Nuciforo P, Oberst S, Oliveiera J, Papatriantafyllou M, Ricciardi W, Roediger A, Ryll B, Schilsky R, Scocca G, Seruca R, Soares M, Steindorf K, Valentini V, Voest E, Weiderpass E, Wilking N, Wren A, Zitvogel L. The Porto European Cancer Research Summit 2021. Mol Oncol. 2021 Oct;15(10):2507-2543. doi: 10.1002/1878-0261.13078
  • Venet D, Rediti M, Maetens M, Fumagalli D, Brown DN, Majjaj S, Salgado R, Pusztai L, Harbeck N, El-Abed S, Wang Y, Saura C, Gomez H, Semiglazov VF, de Azambuja E, Huober J, Nuciforo P, Di Cosimo S, Piccart M, Loi S, Rothé F, Sotiriou C. Copy Number Aberration Analysis to Predict Response to Neoadjuvant Anti-HER2 Therapy: Results from the NeoALTTO Phase III Clinical Trial. Clin Cancer Res. 2021 Oct 15;27(20):5607-5618.
  • Borgognone A, Serna G, Noguera-Julian M, Alonso L, Parera M, Català-Moll F, Sanchez L, Fasani R, Paredes R, Nuciforo P. Performance of 16S Metagenomic Profiling in Formalin-Fixed Paraffin-Embedded versus Fresh-Frozen Colorectal Cancer Tissues. Cancers (Basel). 2021 Oct 29;13(21):5421.
  • Martinez-Marti A, Felip E, Mancuso FM, Caratú G, Matito J, Nuciforo P, Sansano I, Diaz-Mejia N, Cedrés S, Callejo A, Iranzo P, Pardo N, Miquel JM, Navarro A, Vivancos A, Sansó M. Genetic evolution to tyrosine kinase inhibitory therapy in patients with EGFR-mutated non-small-cell lung cancer. Br J Cancer. 2021 Nov;125(11):1561-1569. doi: 10.1038/s41416-021-01558-9.
  • Wurm M, Schaaf O, Reutner K, Ganesan R, Mostböck S, Pelster C, Böttcher J, de Andrade Pereira B, Taubert C, Alt I, Serna G, Auguste A, Stadermann KB, Delic D, Han F, Capdevila J, Nuciforo PG, Kroe-Barrett R, Adam PJ, Vogt AB, Hofmann I. A Novel Antagonistic CD73 Antibody for Inhibition of the Immunosuppressive Adenosine Pathway. Mol Cancer Ther. 2021 Nov;20(11):2250-2261.
  • Pernas S, Villagrasa P, Vivancos A, Scaltriti M, Rodón J, Burgués O, Nuciforo P, Canes J, Paré L, Dueñas M, Vidal M, Cejalvo JM, Perelló A, Llommbard-Cussac A, Dorca J, Montaño A, Pascual T, Oliveira M, Ribas G, Rapado I, Prat A, Ciruelos E. First Nationwide Molecular Screening Program in Spain for Patients With Advanced Breast Cancer: Results From the AGATA SOLTI-1301 Study. Front Oncol. 2021 Nov 4;11:744112.
  • Vathiotis IA, Moutafi MK, Divakar P, Aung TN, Qing T, Fernandez A, Yaghoobi V, El-Abed S, Wang Y, Guillaume S, Nuciforo P, Huober J, Di Cosimo S, Kim SB, Harbeck N, Gomez H, Shafi S, Syrigos KN, Fountzilas G, Sotiriou C, Pusztai L, Warren S, Rimm DL. Alpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast Cancer. Clin Cancer Res. 2021 Nov 15;27(22):6156-6163.
  • Pascual T, Oliveira M, Villagrasa P, Ortega V, Paré L, Bermejo B, Morales S, Amillano K, López R, Galván P, Canes J, Salvador F, Nuciforo P, Rubio IT, Llombart-Cussac A, Di Cosimo S, Baselga J, Harbeck N, Prat A, Cortés J. Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial. NPJ Breast Cancer. 2021 Nov 25;7(1):145.
  • Pizzamiglio S, Ciniselli CM, Triulzi T, Gargiuli C, De Cecco L, de Azambuja E, Fumagalli D, Sotiriou C, Harbeck N, Izquierdo M, Nuciforo P, Huober J, Cappelletti V, Cinieri S, Piccart M, Daidone MG, Pruneri G, Colombo MP, Tagliabue E, Verderio P, Di Cosimo S. Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis. Clin Cancer Res. 2021 Dec 1;27(23):6307-6313.
  • El Bairi K, Haynes HR, Blackley E, Fineberg S, Shear J, Turner S, de Freitas JR, Sur D, Amendola LC, Gharib M, Kallala A, Arun I, Azmoudeh-Ardalan F, Fujimoto L, Sua LF, Liu SW, Lien HC, Kirtani P, Balancin M, El Attar H, Guleria P, Yang W, Shash E, Chen IC, Bautista V, Do Prado Moura JF, Rapoport BL, Castaneda C, Spengler E, Acosta-Haab G, Frahm I, Sanchez J, Castillo M, Bouchmaa N, Md Zin RR, Shui R, Onyuma T, Yang W, Husain Z, Willard-Gallo K, Coosemans A, Perez EA, Provenzano E, Ericsson PG, Richardet E, Mehrotra R, Sarancone S, Ehinger A, Rimm DL, Bartlett JMS, Viale G, Denkert C, Hida AI, Sotiriou C, Loibl S, Hewitt SM, Badve S, Symmans WF, Kim RS, Pruneri G, Goel S, Francis PA, Inurrigarro G, Yamaguchi R, Garcia-Rivello H, Horlings H, Afqir S, Salgado R, Adams S, Kok M, Dieci MV, Michiels S, Demaria S, Loi S; International Immuno-Oncology Biomarker Working Group. The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group. NPJ Breast Cancer. 2021 Dec 1;7(1):150.
  • Shi Z, Wulfkuhle J, Nowicka M, Gallagher RI, Saura C, Nuciforo PG, Calvo I, Andersen J, Passos-Coelho JL, Gil-Gil MJ, Bermejo B, Pratt DA, Ciruelos EM, Villagrasa P, Wongchenko MJ, Petricoin EF, Oliveira M, Isakoff SJ. Functional Mapping of AKT Signaling and Biomarkers of Response from the FAIRLANE Trial of Neoadjuvant Ipatasertib plus Paclitaxel for Triple-Negative Breast Cancer. Clin Cancer Res. 2021 Dec 14. doi: 10.1158/1078-0432.CCR-21-2498. Epub ahead of print. PMID: 34907082.
  • Senís E, Esgleas M, Najas S, Jiménez-Sábado V, Bertani C, Giménez-Alejandre M, Escriche A, Ruiz-Orera J, Hergueta-Redondo M, Jiménez M, Giralt A, Nuciforo P, Albà MM, Peinado H, Del Toro D, Hove-Madsen L, Götz M, Abad M. TUNAR lncRNA Encodes a Microprotein that Regulates Neural Differentiation and Neurite Formation by Modulating Calcium DynamicsFront Cell Dev Biol. 2021 Dec 31;9:747667.
  • Chic, Nuria ; Luen, Stephen J ; NUCIFORO, PAOLO GIOVANNI; Salgado, Roberto ; Fumagalli, Debora ; Hilbers, Florentine ; Wang, Yingbo ; de Azambuja, Evandro ; Làng, István ; DI COSIMO, SERENA; SAURA MANICH, CRISTINA; Huober, Jens ; PRAT APARICIO, ALEIX; Loi, Sherene. Tumor Cellularity and Infiltrating Lymphocytes (CelTIL) as a Survival Surrogate in HER2-Positive Breast Cancer. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE.1093/jnci/djab057
  • Frigola, Joan; NAVARRO MENDIVIL, ALEJANDRO; Carbonell, Caterina ; Callejo, Ana ; Iranzo, Patricia ; CEDRES PEREZ, SUSANA; MARTINEZ MARTI, ALEXANDRE; PARDO ARANDA, NURIA; Saoudi-Gonzalez, Nadia ; Martinez, Debora ; JIMENEZ, JOSE; Sansano, Irene ; MANCUSO, FRANCESCO MATTIA; NUCIFORO, PAOLO GIOVANNI; Montuenga, Luis M ; Sánchez-Cespedes, Montse ; PRAT APARICIO, ALEIX; VIVANCOS PRELLEZO, ANA; FELIP FONT, ENRIQUETA; AMAT FERRER, RAMON. Molecular profiling of long-term responders to immune checkpoint inhibitors in advanced non-small cell lung cancer. MOLECULAR ONCOLOGY. 2021 April. 10.1002/1878-0261.12891
  • LIGERO HERNANDEZ, MARTA; Garcia-Ruiz, Alonso ; VIAPLANA DONATO, CRISTINA; VILLACAMPA JAVIERRE, GUILLERMO; Raciti, Maria V ; Landa, Jaid ; MATOS GARCIA, IGNACIO; MARTIN LIBERAL, JUAN JESUS; OCHOA DE OLZA AMAT, MARIA; HIERRO CARBO, CINTA; MATEO VALDERRAMA, JOAQUIN; Gonzalez, Macarena ; MORALES BARRERA, RAFAEL; SUAREZ RODRIGUEZ, CRISTINA; RODON AHNERT, JORDI; ELEZ FERNANDEZ, MARIA ELENA; BRAÑA GARCIA, IRENE; MUÑOZ COUSELO, EVA; OAKNIN BENZAQUEN, ANA MAZALTOB; FASANI, ROBERTA; NUCIFORO, PAOLO GIOVANNI; Gil, Debora ; RUBIO, ISABEL TERESA; SEOANE SUAREZ, JOAN; FELIP FONT, ENRIQUETA; Escobar, Manuel ; TABERNERO CATURLA, JOSEP; CARLES GALCERAN, JOAN; DIENSTMANN, RODRIGO; GARRALDA CABANAS, ELENA; PEREZ LOPEZ, RAQUEL. A CT-based Radiomics Signature Is Associated with Response to Immune Checkpoint Inhibitors in Advanced Solid Tumors. Radiology. 2021 April. 10.1148/radiol.2021200928
  • RUBIO PEREZ, CARLOTA; Planas-Rigol, Ester ; Trincado, Juan L ; BONFILL TEIXIDOR, ESTER; ARIAS PIÑEIRO, ALEXANDRA; Marchese, Domenica ; Moutinho, Catia ; SERNA ALONSO, GARAZI; Pedrosa, Leire ; IURLARO, RAFFAELLA; Martínez-Ricarte, Francisco ; ESCUDERO MONREAL, LAURA; Cordero, Esteban ; Cicuendez, Marta ; Ruiz, Sara ; Parra, Genís ; NUCIFORO, PAOLO GIOVANNI; Gonzalez, Josep ; Pineda, Estela ; Sahuquillo, Juan ; TABERNERO CATURLA, JOSEP; Heyn, Holger ; SEOANE SUAREZ, JOAN. Immune cell profiling of the cerebrospinal fluid enables the characterization of the brain metastasis microenvironment. NATURE COMMUNICATIONS. 2020 March. 10.1038/s41467-021-21789-x
  • Oliva, Marc ; MULET MARGALEF, NURIA; OCHOA DE OLZA AMAT, MARIA; Napoli, Stefania ; Mas, Joan ; Laquente, Berta ; Alemany, Laia ; Duell, Eric J ; NUCIFORO, PAOLO GIOVANNI; Moreno, Victor. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. Tumor-Associated Microbiome: Where Do We Stand?. 2021 February. 10.3390/ijms22031446
  • Hudecek, J. ; Voorwerk, L. ; van Seijen, M. ; Nederlof, I. ; de Maaker, M. ; van den Berg, J. ; van de Vijver, K.K. ; Sikorska, K. ; Adams, S. ; Demaria, S. ; Viale, G. ; Nielsen, T.O. ; Badve, S.S. ; Michiels, S. ; Symmans, W.F. ; Sotiriou, C. ; Rimm, D.L. ; Hewitt, S.M. ; Denkert, C. ; Loibl, S. ; Loi, S. ; Bartlett, J.M.S. ; Pruneri, G. ; Dillon, D.A. ; Cheang, M.C.U. ; Tutt, A. ; Hall, J.A. ; Kos, Z. ; Salgado, R. ; Kok, M. ; Horlings, H.M. ; Hyytiäinen, A. ; Hida, A.I. ; Thompson, A. ; Lefevre, A. ; Lazar, A.J. ; Gown, A. ; Lo, A. ; Sapino, A. ; Madabhushi, A. ; Moreira, A. ; Richardson, A. ; Vingiani, A. ; Beck, A.H. ; Bellizzi, A.M. ; Guerrero, A. ; Grigoriadis, A. ; Ehinger, A. ; Garrido-Castro, A. ; Vincent-Salomon, A. ; Laenkholm, A.-V. ; Sharma, A. ; Cimino-Mathews, A. ; Srinivasan, A. ; Acs, B. ; Singh, B. ; Calhoun, B. ; Haibe-Kans, B. ; Solomon, B. ; Thapa, B. ; Nelson, B.H. ; Gallas, B.D. ; Castaneda, C. ; Ballesteros-Merino, C. ; Criscitiello, C. ; Boeckx, C. ; Colpaert, C. ; Quinn, C. ; Chennubhotla, C.S. ; Swanton, C. ; Solinas, C. ; Hiley, C. ; Drubay, D. ; Bethmann, D. ; Moore, D.A. ; Larsimont, D. ; Sabanathan, D. ; Peeters, D. ; Zardavas, D. ; Höflmayer, D. ; Johnson, D.B. ; Thompson, E.A. ; Brogi, E. ; Perez, E. ; ElGabry, E.A. ; Stovgaard, E.S. ; Blackley, E.F. ; Roblin, E. ; Reisenbichler, E. ; Bellolio, E. ; Balslev, E. ; Chmielik, E. ; Gaire, F. ; Andre, F. ; Lu, F.-I. ; Azmoudeh-Ardalan, F. ; Rojo, F. ; Gruosso, T. ; Ciompi, F. ; Peale, F. ; Hirsch, F.R. ; Klauschen, F. ; Penault-Llorca, F. ; Acosta Haab, G. ; Farshid, G. ; van den Eynden, G. ; Curigliano, G. ; Floris, G. ; Broeckx, G. ; Gonzalez-Ericsson ; Koeppen, H. ; Haynes, H.R. ; McArthur, H. ; Joensuu, H. ; Olofsson, H. ; Lien, H.-C. ; Chen, I.-C. ; Cree, I. ; Frahm, I. ; Brcic, I. ; Chan, J. ; Ziai, J. ; Brock, J. ; Wesseling, J. ; Giltnane, J. ; Kerner, J.K. ; Thagaard, J. ; Braybrooke, J.P. ; van der Laak, J.A.W.M. ; Lemonnier, J. ; Zha, J. ; Ribeiro, J. ; Lennerz, J.K. ; Carter, J.M. ; Saltz, J. ; Hartman, J. ; Hainfellner, J. ; Quesne, J.L. ; Juco, J.W. ; Reis-Filho, J. ; Sanchez, J. ; Sparano, J. ; Cucherousset, J. ; Araya, J.C. ; Adam, J. ; Balko, J.M. ; Saeger, K. ; Siziopikou, K. ; Willard-Gallo, K. ; Weber, K. ; Pogue-Geile, K.L. ; Steele, K.E. ; Emancipator, K. ; AbdulJabbar, K. ; El Bairi, K. ; Blenman, K.R.M. ; Allison, K.H. ; Korski, K. ; Pusztai, L. ; Comerma, L. ; Buisseret, L. ; Cooper, L.A.D. ; Shi, L. ; Kooreman, L.F.S. ; Molinero, L. ; Estrada, M.V. ; Lacroix-Triki, M. ; Al Bakir, M. ; Sebastian, M.M. ; van de Vijver, M. ; Balancin, M.L. ; Dieci, M.V. ; Mathieu, M.-C. ; Rebelatto, M.C. ; Piccart, M. ; Hanna, M.G. ; Goetz, M.P. ; Preusser, M. ; Khojasteh, M. ; Sanders, M.E. ; Regan, M.M. ; Barnes, M. ; Christie, M. ; Misialek, M. ; Ignatiadis, M. ; van Bockstal, M. ; Castillo, M. ; Amgad, M. ; Harbeck, N. ; Tung, N. ; Laudus, N. ; Sirtaine, N. ; Burchardi, N. ; Ternes, N. ; Radosevic-Robin, N. ; Gluz, O. ; Grimm, O. ; NUCIFORO, PAOLO GIOVANNI; Jank, P. ; Gonzalez-Ericsson, P. ; Kirtani, P. ; Jelinic, P. ; Watson, P.H. ; Savas, P. ; Francis, P.A. ; Russell, P.A. ; Singh, R. ; Kim, R.S. ; Pierce, R.H. ; Hills, R. ; Leon-Ferre, R. ; de Wind, R. ; Shui, R. ; De Clercq, S. ; Leung, S. ; Tabbarah, S. ; Souza, S.C. ; O’Toole, S. ; Swain, S. ; Dudgeon, S. ; Willis, S. ; Ely, S. ; Kim, S.-R. ; Bedri, S. ; Irshad, S. ; Liu, S.-W. ; Goel, S. ; Hendry, S. ; Bianchi, S. ; Bragança, S. ; Paik, S. ; Wienert, S. ; Fox, S.B. ; Luen, S.J. ; Naber, S. ; Schnitt, S.J. ; Sua, L.F. ; Lakhani, S.R. ; Fineberg, S. ; Soler, T. ; Gevaert, T. ; D’Alfonso, T. ; John, T. ; Sugie, T. ; Kurkure, U. ; Bossuyt, V. ; Manem, V. ; Cámara, V.P. ; Tong, W. ; Chen, W. ; Yang, W. ; Tran, W.T. ; Wang, Y. ; Yuan, Y. ; Allory, Y. ; Husain, Z. ; Bago-Horvath, Z. Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials. NPJ breast cancer. 2020 January. 10.1038/s41523-020-0155-1
  • Chic, Nuria ; Luen, Stephen J ; NUCIFORO, PAOLO GIOVANNI; Salgado, Roberto ; Fumagalli, Debora ; Hilbers, Florentine ; Wang, Yingbo ; de Azambuja, Evandro ; Làng, István ; DI COSIMO, SERENA; SAURA MANICH, CRISTINA; Huober, Jens ; PRAT APARICIO, ALEIX; Loi, Sherene. HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade.  JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2020 January. 10.1093/jnci/djz042
  • CAPDEVILA CASTILLON, JAUME; MATOS GARCIA, IGNACIO; MANCUSO, FRANCESCO MATTIA; Iglesias, Carmela; NUCIFORO, PAOLO GIOVANNI; Zafon, Carles ; GARCIA PALMER, HECTOR; OGBAH, ZIGHEREDA; Muinos, Laura ; HERNANDO CUBERO, JORGE; Villacampa, Guillermo ; Peña, Carol E ; TABERNERO CATURLA, JOSEP; Brose, Marcia S ; Schlumberger, Martin ; VIVANCOS PRELLEZO, ANA. Identification of Expression Profiles Defining Distinct Prognostic Subsets of Radioactive-Iodine Refractory Differentiated Thyroid Cancer from the DECISION Trial. MOLECULAR CANCER THERAPEUTICS. 2020 January. 10.1158/1535-7163.MCT-19-0211
  • Cebrià-Costa, J P ; PASCUAL REGUANT, LAURA; Gonzalez-Perez, A ; Serra-Bardenys, G ; QUEROL PAÑOL, JESSICA; Cosín, M ; Verde, G ; Cigliano, R A ; Sanseverino, W ; Segura-Bayona, S ; Iturbide, A ; Andreu, D ; NUCIFORO, PAOLO GIOVANNI; Bernado-Morales, C ; RODILLA BENITO, VERONICA; ARRIBAS LOPEZ, JOAQUIN VICENTE; Yelamos, J ; de Herreros, A Garcia ; Stracker, T H ; PEIRO SALES, SANDRA. LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells. 2020 January. 10.1038/s41388-019-0969-1
  • NUCIFORO, PAOLO GIOVANNI; Townend, J. ; SAURA MANICH, CRISTINA; de Azumbaja, E. ; Hilbers, F. ; Manukyants, A. ; Werutsky, G. ; Bliss, J. ; Moebus, V. ; Colleoni, M. ; Aspitia, A.M. ; Di Cosimo, S. ; Van dooren, V. ; Kroep, J. ; Ferro, A. ; Cameron, D. ; Gelber, R. ; Piccart-Gebhart, M. ; Huober, J. Nine-year survival outcome of neoadjuvant lapatinib with trastuzumab for HER2-positive breast cancer (NeoALTTO, BIG 1-06): final analysis of a multicentre, open-label, phase 3 randomised clinical trial. EUROPEAN JOURNAL OF CANCER. 2020 January. 10.1016/S0959-8049(20)30560-8
  • Amgad, Mohamed ; Stovgaard, Elisabeth Specht ; Balslev, Eva ; Thagaard, Jeppe ; Chen, Weijie ; Dudgeon, Sarah ; Sharma, Ashish ; Kerner, Jennifer K ; Denkert, Carsten ; Yuan, Yinyin ; AbdulJabbar, Khalid ; Wienert, Stephan ; Savas, Peter ; Voorwerk, Leonie ; Beck, Andrew H ; Madabhushi, Anant ; Hartman, Johan ; Sebastian, Manu M ; Horlings, Hugo M ; Hudecek, Jan ; Ciompi, Francesco ; Moore, David A ; Singh, Rajendra ; Roblin, Elvire ; Balancin, Marcelo Luiz ; Mathieu, Marie-Christine ; Lennerz, Jochen K ; Kirtani, Pawan ; Chen, I-Chun ; Braybrooke, Jeremy P ; Pruneri, Giancarlo ; Demaria, Sandra ; Adams, Sylvia ; Schnitt, Stuart J ; Lakhani, Sunil R ; Rojo, Federico ; Comerma, Laura ; Badve, Sunil S ; Khojasteh, Mehrnoush ; Symmans, W Fraser ; Sotiriou, Christos ; Gonzalez-Ericsson, Paula ; Pogue-Geile, Katherine L ; Kim, Rim S ; Rimm, David L ; Viale, Giuseppe ; Hewitt, Stephen M ; Bartlett, John M S ; Penault-Llorca, Frédérique ; Goel, Shom ; Lien, Huang-Chun ; Loibl, Sibylle ; Kos, Zuzana ; Loi, Sherene ; Hanna, Matthew G ; Michiels, Stefan ; Kok, Marleen ; Nielsen, Torsten O ; Lazar, Alexander J ; Bago-Horvath, Zsuzsanna ; Kooreman, Loes F S ; van der Laak, Jeroen A W M ; Saltz, Joel ; Gallas, Brandon D ; Kurkure, Uday ; Barnes, Michael ; Salgado, Roberto ; Hyytiäinen, Aini ; International Immuno-Oncology Biomarker Working Group ; Hida, Akira I ; Thompson, Alastair ; Lefevre, Alex ; Gown, Allen ; Lo, Amy ; Sapino, Anna ; Moreira, Andre ; Richardson, Andrea ; Vingiani, Andrea ; Bellizzi, Andrew M ; Tutt, Andrew ; Guerrero-Zotano, Angel ; Grigoriadis, Anita ; Ehinger, Anna ; Garrido-Castro, Anna C ; Vincent-Salomon, Anne ; Laenkholm, Anne-Vibeke ; Cimino-Mathews, Ashley ; Srinivasan, Ashok ; Acs, Balazs ; Singh, Baljit ; Calhoun, Benjamin ; Haibe-Kans, Benjamin ; Solomon, Benjamin ; Thapa, Bibhusal ; Nelson, Brad H ; Castaneda, Carlos ; Ballesteroes-Merino, Carmen ; Criscitiello, Carmen ; Boeckx, Carolien ; Colpaert, Cecile ; Quinn, Cecily ; Chennubhotla, Chakra S ; Swanton, Charles ; Solinas, Cinzia ; Hiley, Crispin ; Drubay, Damien ; Bethmann, Daniel ; Dillon, Deborah A ; Larsimont, Denis ; Sabanathan, Dhanusha ; Peeters, Dieter ; Zardavas, Dimitrios ; Höflmayer, Doris ; Johnson, Douglas B ; Thompson, E Aubrey ; Brogi, Edi ; Perez, Edith ; ElGabry, Ehab A ; Blackley, Elizabeth F ; Reisenbichler, Emily ; Bellolio, Enrique ; Chmielik, Ewa ; Gaire, Fabien ; Andre, Fabrice ; Lu, Fang-I ; Azmoudeh-Ardalan, Farid ; Gruosso, Forbius Tina ; Peale, Franklin ; Hirsch, Fred R ; Klaushen, Frederick ; Acosta-Haab, Gabriela ; Farshid, Gelareh ; van den Eynden, Gert ; Curigliano, Giuseppe ; Floris, Giuseppe ; Broeckx, Glenn ; Koeppen, Harmut ; Haynes, Harry R ; McArthur, Heather ; Joensuu, Heikki ; Olofsson, Helena ; Cree, Ian ; Nederlof, Iris ; Frahm, Isabel ; Brcic, Iva ; Chan, Jack ; Hall, Jacqueline A ; Ziai, James ; Brock, Jane ; Wesseling, Jelle ; Giltnane, Jennifer ; Lemonnier, Jerome ; Zha, Jiping ; M Ribeiro, Joana ; Carter, Jodi M ; Hainfellner, Johannes ; Quesne, John Le ; Juco, Jonathan W ; Reis-Filho, Jorge ; van den Berg, Jose ; Sanchez, Joselyn ; Sparano, Joseph ; Cucherousset, Joël ; Araya, Juan Carlos ; Adam, Julien ; Balko, Justin M ; Saeger, Kai ; Siziopikou, Kalliopi ; Willard-Gallo, Karen ; Sikorska, Karolina ; Weber, Karsten ; Steele, Keith E ; Emancipator, Kenneth ; El Bairi, Khalid ; Blenman, Kim R M ; Allison, Kimberly H ; van de Vijver, Koen K ; Korski, Konstanty ; Pusztai, Lajos ; Buisseret, Laurence ; Shi, Leming ; Shi-Wei, Liu ; Molinero, Luciana ; Estrada, M Valeria ; van Seijen, Maartje ; Lacroix-Triki, Magali ; Cheang, Maggie C U ; Bakir, Maise Al ; van de Vijver, Marc ; Dieci, Maria Vittoria ; Rebelatto, Marlon C ; Piccart, Martine ; Goetz, Matthew P ; Preusser, Matthias ; Sanders, Melinda E ; Regan, Meredith M ; Christie, Michael ; Misialek, Michael ; Ignatiadis, Michail ; de Maaker, Michiel ; van Bockstal, Mieke ; Castillo, Miluska ; Harbeck, Nadia ; Tung, Nadine ; Laudus, Nele ; Sirtaine, Nicolas ; Burchardi, Nicole ; Ternes, Nils ; Radosevic-Robin, Nina ; Gluz, Oleg ; Grimm, Oliver ; Nuciforo, Paolo ; NUCIFORO, PAOLO GIOVANNI; Jelinic, Petar ; Watson, Peter H ; Francis, Prudence A ; Russell, Prudence A ; Pierce, Robert H ; Hills, Robert ; Leon-Ferre, Roberto ; de Wind, Roland ; Shui, Ruohong ; Declercq, Sabine ; Leung, Sam ; Tabbarah, Sami ; Souza, Sandra C ; O’Toole, Sandra ; Swain, Sandra ; Willis, Scooter ; Ely, Scott ; Kim, Seong- Rim ; Bedri, Shahinaz ; Irshad, Sheeba ; Liu, Shi-Wei ; Hendry, Shona ; Bianchi, Simonetta ; Bragança, Sofia ; Paik, Soonmyung ; Fox, Stephen B ; Luen, Stephen J ; Naber, Stephen ; Luz, Sua ; Fineberg, Susan ; Soler, Teresa ; Gevaert, Thomas ; d’Alfons, Timothy ; John, Tom ; Sugie, Tomohagu ; Bossuyt, Veerle ; Manem, Venkata ; Cámaea, Vincente Peg ; Tong, Weida ; Yang, Wentao ; Tran, William T ; Wang, Yihong ; Allory, Yves ; Husain, Zaheed ; Husain Z. Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group.  NPJ breast cancer. 2020 January. 10.1038/s41523-020-0154-2
  • Brasó-Maristany, Fara ; Griguolo, Gaia ; Pascual, Tomás ; Paré, Laia ; NUCIFORO, PAOLO GIOVANNI; Llombart-Cussac, Antonio ; Bermejo, Begoña ; ANTUNES DE MELO E OLIVEIRA, MAFALDA; Morales, Serafín ; Martínez, Noelia ; VIDAL LOSADA, Mª JESUS; Adamo, Barbara ; Martínez, Olga ; Pernas, Sonia ; López, Rafael ; Muñoz, Montserrat ; Chic, Núria ; Galván, Patricia ; Garau, Isabel ; Manso, Luis ; Alarcón, Jesús ; Martínez, Eduardo ; Gregorio, Sara ; Gomis, Roger R ; Villagrasa, Patricia ; CORTES CASTAN, JAVIER; Ciruelos, Eva ; Prat, Aleix. Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade. NATURE COMMUNICATIONS. 2020 January. 10.1038/s41467-019-14111-3
  • Di Cosimo, Serena ; Appierto, Valentina ; Pizzamiglio, Sara ; Silvestri, Marco ; Baselga, José ; Piccart, Martine ; Huober, Jens ; Izquierdo, Miguel ; de la Pena, Lorena ; Hilbers, Florentine S ; de Azambuja, Evandro ; Untch, Michael ; Pusztai, Lajos ; Pritchard, Kathleen ; NUCIFORO, PAOLO GIOVANNI; Vincent-Salomon, Anne ; Symmans, Fraser ; Apolone, Giovanni ; de Braud, Filippo G ; Iorio, Marilena V ; Verderio, Paolo ; Daidone, Maria Grazia. Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant Therapy. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2020 February. 10.3390/ijms21041386
  • De Angelis, Carmine; Nagi, Chandandeep ; Hoyt, Cliff C ; Liu, Linying ; Roman, Kristin ; Wang, Chichung ; Zheng, Yi ; Veeraraghavan, Jamunarani ; Sethunath, Vidyalakshmi ; NUCIFORO, PAOLO GIOVANNI; Wang, Tao ; Tsimelzon, Anna ; Mao, Sufeng ; Hilsenbeck, Susan G ; Trivedi, Meghana V ; Cataldo, Maria Letizia ; Pavlick, Anne ; Wolff, Antonio C ; Weigelt, Britta ; Reis-Filho, Jorge S ; Prat, Aleix ; Gutierrez, Carolina ; Osborne, Charles Kent ; Rimawi, Mothaffar F ; Schiff, Rachel. Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without CLINICAL CANCER RESEARCH. 2020 February. 10.1158/1078-0432.CCR-19-1402
  • CAPDEVILA CASTILLON, JAUME; ARQUES CASAMITJANA, ORIOL; Hernandez Mora, Jose Ramon ; MATITO ARIZA, JUDIT; CARATU, GINEVRA; MANCUSO, FRANCESCO MATTIA; Landolfi, Stefania ; Barriuso, Jorge ; Jimenez-Fonseca, Paula ; Lopez Lopez, Carlos ; Garcia-Carbonero, Rocio ; Hernando, Jorge ; MATOS GARCIA, IGNACIO; NUCIFORO, PAOLO GIOVANNI; Hernández-Losa, Javier ; Esteller, Manel ; Martínez-Cardús, Anna ; TABERNERO CATURLA, JOSEP; VIVANCOS PRELLEZO, ANA; GARCIA PALMER, HECTOR. Epigenetic EGFR Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas. CLINICAL CANCER RESEARCH. 2020 February. 10.1158/1078-0432.CCR-19-1266
  • GARCIA VALVERDE, LUIS ALFONSO; Rosell, Jordi; Serna, Garazi ; VALVERDE MORALES, CLAUDIA M; CARLES GALCERAN, JOAN; NUCIFORO, PAOLO GIOVANNI; Fletcher, Jonathan A ; ARRIBAS LOPEZ, JOAQUIN VICENTE; Politz, Oliver ; SERRANO GARCIA, CESAR. Preclinical Activity of PI3K Inhibitor Copanlisib in Gastrointestinal Stromal Tumor. MOLECULAR CANCER THERAPEUTICS. 2020 June. 1158/1535-7163.MCT-19-1069
  • Tamborero, David ; DIENSTMANN, RODRIGO; Rachid, Maan Haj ; Boekel, Jorrit ; Baird, Richard ; BRAÑA GARCIA, IRENE; De Petris, Luigi ; Yachnin, Jeffrey ; Massard, Christophe ; Opdam, Frans L ; Schlenk, Richard ; Vernieri, Claudio ; GARRALDA CABANAS, ELENA; Masucci, Michele ; VILLALOBOS ALBERU, XENIA; CHAVARRIA MIRAS, ELENA; Cancer Core Europe consortium ; Calvo, Fabien ; Fröhling, Stefan ; Eggermont, Alexander ; Apolone, Giovanni ; Voest, Emile E ; Caldas, Carlos ; TABERNERO CATURLA, JOSEP; Ernberg, Ingemar ; RODON AHNERT, JORDI; Lehtiö, Janne ; Anand, Shubha ; AZARO, ANALIA BEATRIZ; Baars, Danny ; Bajalica-Lagercrantz, Svetlana ; BALMAÑA GELPI, JUDITH; Bergh, Jonas ; Bierkens, Mariska ; Blomqvist, Lennart ; Doherty, Gary J ; Forest, Arnauld ; Fornerone, Valentina ; Funingana, Ionut Gabriel ; Gabaldi, Paola ; Hartman, Johan ; Horak, Peter ; Karlsson, Claes ; Kasanicki, Mary ; Kreutzfeldt, Simon ; Lewensohn, Rolf ; Lindberg, Johan ; Lopez, Carlos ; Lundqvist, Andreas ; Martin-Romano, Patricia ; Martin, Jose-Ezequiel ; Meijer, Gerrit ; Muñoz, Susana ; Camus, Maud Ngo ; Nicotra, Claudio ; NUCIFORO, PAOLO GIOVANNI; Oberrauch, Petra ; Östling, Päivi ; PIRIS GIMENEZ, ALEJANDRO; Provenzano, Elena ; Rouleau, Etienne ; Rowell, John ; SAAVEDRA SANTAGADEA, OMAR; Valdivia, Ignacio Sánchez ; Scoazec, Giovanni ; Seamon, Kenneth ; Tischkowitz, Marc ; van der Kolk, Lizet ; van der Noll, Ruud ; Vis, Daniel ; VIVANCOS PRELLEZO, ANA; von Gertten, Christina ; Wennborg, Anders ; Wessels, Lodewyk ; Wirta, Valtteri ; Wolfart, Julia. Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal. NATURE MEDICINE. 2020 July. 10.1038/s41591-020-0969-2
  • GRIS OLIVER, ALBERT; PALAFOX SANCHEZ, MARTA; MONTSERRAT VICENTE, LAIA; Brasó-Maristany, Fara ; Òdena, Andreu ; SANCHEZ GUIXE, MONICA; IBRAHIM, YASIR HUSSEIN; VILLACAMPA JAVIERRE, GUILLERMO; GRUESO GRAGERA, JUDIT; Parés, Mireia ; GUZMAN, MARTA; RODRIGUEZ FERREIRO, OLGA; Bruna, Alejandra ; Hirst, Caroline S ; Barnicle, Alan ; de Bruin, Elza C ; Reddy, Avinash ; Schiavon, Gaia ; ARRIBAS LOPEZ, JOAQUIN VICENTE; Mills, Gordon B ; Caldas, Carlos ; Dienstman, Rodrigo ; PRAT APARICIO, ALEIX; NUCIFORO, PAOLO GIOVANNI; Razavi, Pedram ; SCALTRITI, MAURIZIO; Turner, Nicholas C ; SAURA MANICH, CRISTINA; Davies, Barry R ; Oliveira, Mafalda ; SERRA ELIZALDE, VIOLETA. Genetic Alterations in the PI3K/AKT Pathway and Baseline AKT Activity Define AKT Inhibitor Sensitivity in Breast Cancer Patient-derived Xenografts. CLINICAL CANCER RESEARCH. 1158/1078-0432.CCR-19-3324
  • Lupo, Barbara ; Sassi, Francesco ; Pinnelli, Marika ; Galimi, Francesco ; Zanella, Eugenia R ; Vurchio, Valentina ; Migliardi, Giorgia ; Gagliardi, Paolo Armando ; Puliafito, Alberto ; Manganaro, Daria ; Luraghi, Paolo ; Kragh, Michael ; Pedersen, Mikkel W ; Horak, Ivan D ; Boccaccio, Carla ; Medico, Enzo ; Primo, Luca ; Nichol, Daniel ; Spiteri, Inmaculada ; Heide, Timon ; Vatsiou, Alexandra ; Graham, Trevor A ; ELEZ FERNANDEZ, MARIA ELENA; ARGILES MARTINEZ, GUILLERMO; NUCIFORO, PAOLO GIOVANNI; Sottoriva, Andrea ; DIENSTMANN, RODRIGO; Pasini, Diego ; Grassi, Elena ; Isella, Claudio ; Bertotti, Andrea ; Trusolino, Livio. Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell-like phenotype. SCIENCE TRANSLATIONAL MEDICINE. 2020 August. 10.1126/scitranslmed.aax8313
  • Ciruelos, Eva M ; Villagrasa, Patricia ; Pascual, Tomás ; Oliveira, Mafalda ; Pernas, Sonia ; Paré, Laia ; ESCRIVA DE ROMANI MUÑOZ, SANTIAGO; Manso, Luis ; Adamo, Barbara ; Martínez de Dueñas, Eduardo ; CORTES CASTAN, JAVIER; Vázquez, Silvia ; Perelló, Antonia ; Garau, Isabel ; Melé, Mireia ; Martínez Jañez, Noelia ; Montaño, Alvaro ; Bermejo, Begoña ; Morales, Serafín ; Echarri, Mª Jose ; Vega, Estela ; González-Farré, Blanca ; Martínez, Débora ; GALVAN JURADO, PATRICIA; Canes, Jordi ; NUCIFORO, PAOLO GIOVANNI; Gonzàlez Farré, Xavier ; Prat, Aleix. Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial. CLINICAL CANCER RESEARCH. 2020 November. 1158/1078-0432.CCR-20-0844
  • Zunder, Stéphanie M ; PEREZ LOPEZ, RAQUEL; de Kok, Bente M ; Raciti, Maria Vittoria ; van Pelt, Gabi W ; DIENSTMANN, RODRIGO; Garcia-Ruiz, Alonso ; Meijer, C Arnoud ; Gelderblom, Hans ; Tollenaar, Rob A ; NUCIFORO, PAOLO GIOVANNI; Wasser, Martin N ; Mesker, Wilma E. Correlation of the tumour-stroma ratio with diffusion weighted MRI in rectal cancer. EUROPEAN JOURNAL OF RADIOLOGY. 2020 December. 10.1016/j.ejrad.2020.109345
  • Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer. Serna G, Ruiz-Pace F, Cecchi F, Fasani R, Jimenez J, Thyparambil S, Landolfi S, Elez E, Vivancos A, Hembrough T, Tabernero J, Dienstmann R, Nuciforo P. Sci Rep. 2019 Sep 19;9(1):13568.
  • Early evolutionary divergence between papillary and anaplastic thyroid cancers. Capdevila J, Mayor R, Mancuso FM, Iglesias C, Caratú G, Matos I, Zafón C, Hernando J, Petit A, Nuciforo P, Cameselle-Teijeiro JM, Álvarez CV, Recio JA, Tabernero J, Matias-Guiu X, Vivancos A, Seoane J. Ann Oncol. 2019 Nov 1;30(11):1843.
  • Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS-mutant metastatic colorectal cancer.Elez E, Chianese C, Sanz-García E, Martinelli E, Noguerido A, Mancuso FM, Caratù G, Matito J, Grasselli J, Cardone C, Esposito Abate R, Martini G, Santos C, Macarulla T, Argilés G, Capdevila J, Garcia A, Mulet N, Maiello E, Normanno N, Jones F, Tabernero J, Ciardello F, Salazar R, Vivancos A. Mol Oncol. 2019 Sep;13(9):1827-1835.
  • Comparison of the Clinical Sensitivity of the Idylla Platform and the OncoBEAM RAS CRC Assay for KRAS Mutation Detection in Liquid Biopsy Samples. Vivancos A, Aranda E, Benavides M, Élez E, Gómez-España MA, Toledano M, Alvarez M, Parrado MRC, García-Barberán V, Diaz-Rubio E. Sci Rep. 2019 Jun 20;9(1):8976.
  • Genomic heterogeneity and efficacy of PI3K pathway inhibitors in patients with gynaecological cancer. Rodriguez-Freixinos V, Ruiz-Pace F, Fariñas-Madrid L, Garrido-Castro AC, Villacampa G, Nuciforo P, Vivancos A, Dienstmann R, Oaknin A. ESMO Open. 2019 Mar 8;4(2):e000444.
  • Vivancos A, Élez E, Salazar R. Circulating cell-free DNA as predictor of treatment failure after neoadjuvant chemoradiotherapy before surgery in patients with locally advanced rectal cancer: is it ready for primetime? Ann Oncol.29: 532-534.
  • Capdevila J, Mayor R; Mancuso FF, Iglesias C; Caratù G, Matos I, Zafón C, Hernando J, Petit A, Nuciforo P, Cameselle-Teijeiro JM, Álvarez C, Recio JA, Tabernero J, Matias-Guiu X, Vivancos A, Seoane J. Early evolutionary divergence between papillary and anaplastic thyroid cancers. Ann Oncol.29: 1454-1460.
  • Cedrés S, Felip E, Cruz C, Martinez de Castro A, Pardo N, Navarro A, Martinez-Marti A, Remon J, Zeron-Medina J, Balmaña J, Llop-Guevara A, Miquel JM, Sansano I, Nuciforo P, Mancuso F, Serra V, Vivancos A. Activity of HSP90 Inhibiton in a Metastatic Lung Cancer Patient With a Germline BRCA1 Mutation. J Natl Cancer Inst. 110: 914-917.
  • Puig I, Tenbaum SP, Chicote I, Arqués O, Martínez-Quintanilla J, Cuesta-Borrás E, Ramírez L, Gonzalo P, Soto A, Aguilar S, Eguizabal C, Caratù G, Prat A, Argilés G, Landolfi S, Casanovas O, Serra V, Villanueva A, Arroyo AG, Terracciano L, Nuciforo P, Seoane J, Recio JA, Vivancos A, Dienstmann R, Tabernero J, Palmer HG. TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence. J Clin Invest. 128: 3887-3905.
  • Cruz C, Castroviejo-Bermejo M, Gutiérrez-Enríquez S, Llop-Guevara A, Ibrahim YH, Gris-Oliver A, Bonache S, Morancho B, Bruna A, Rueda OM, Lai Z, Polanska UM, Jones GN; Kristel P, de Bustos L, Guzman M, Rodriguez O, Grueso J, Montalban G, Caratú G, Mancuso F, Fasani R, Jiménez J, Howat WJ, Dougherty B, Vivancos A, Nuciforo P, Serres-Créixams X, Rubio IT, Oaknin A, Cadogan E, Barrett JC, Caldas C, Baselga J, Saura C, Cortés J, Arribas J, Jonkers J, Díez O; O’Connor MJ, Balmaña J, Serra V. RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer. Ann Oncol. 29: 1203-1210.
  • Martínez-Ricarte F, Mayor R, Martínez-Sáez E, Rubio-Pérez C, Pineda E, Cordero E, Cicuéndez M, Poca MA, Lopez-Bigas N, Ramón Y Cajal S, Vieito M, Carles J, Tabernero J, Vivancos A, Gallego S, Graus F, Sahuquillo J, Seoane J. Molecular Diagnosis of Diffuse Gliomas through Sequencing of Cell-Free Circulating Tumor DNA from Cerebrospinal Fluid. Clin Cancer Res. 24: 2812-2819.
  • Martinez-Marti A, Felip E, Matito J, Mereu E, Navarro A, Cedrés S, Pardo N, Martinez de Castro A, Remon J, Miquel J M, Guillaumet-Adkins A, Nadal E, Rodriguez-Esteban G, Arqués O, Fasani R, Nuciforo P, Heyn H, Villanueva A, Palmer H G, Vivancos A. Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC). Ann Oncol. 2017 Oct 1;28(10):2451-2457.
  • García-Foncillas J, Alba E, Aranda E, Díaz-Rubio E, López-López R, Tabernero J, Vivancos A. Incorporating BEAMing technology as a liquid biopsy into clinical practice for the management of colorectal cancer patients: an expert taskforce review. Ann Oncol. 2017 Dec 1;28(12):2943-2949.
  • Dienstmann R, Elez E, Argiles G, Matos I, Sanz-Garcia E, Ortiz C, Macarulla T, Capdevila J, Alsina M, Sauri T, Verdaguer H, Vilaro M, Ruiz-Pace F, Viaplana C, Garcia A, Landolfi S, Palmer HG, Nuciforo P, Rodon J, Vivancos A, Tabernero J. Analysis of mutant allele fractions in driver genes in colorectal cancer – biological and clinical insights. Mol Oncol. 2017 Sep;11(9):1263-1272.
  • Grasselli J, Elez E, Caratù G, Matito J, Santos C, Macarulla T, Vidal J, Garcia M, Viéitez JM, Paéz D, Falcó E, Lopez Lopez C, Aranda E, Jones F, Sikri V, Nuciforo P, Fasani R, Tabernero J, Montagut C, Azuara D, Dienstmann R, Salazar R, Vivancos A. Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer. Ann Oncol. 2017 Jun 1;28(6):1294-1301.
  • Pérez-Alea M, Vivancos A, Caratú G, Matito J, Ferrer B, Hernandez-Losa J, Cortés J, Muñoz E, Garcia-Patos V, Recio JA. Genetic profile of GNAQ-mutated blue melanocytic neoplasms reveals mutations in genes linked to genomic instability and the PI3K pathway. Oncotarget. 2016 May 10;7(19):28086-95. doi: 10.18632/oncotarget.8578.
  • Arqués O, Chicote I, Puig I, Tenbaum SP, Argilés G, Dienstmann R, Fernández N, Caratù G, Matito J, Silberschmidt D, Rodon J, Landolfi S, Prat A, Espín E, Charco R, Nuciforo P, Vivancos A, Shao W, Tabernero J, Palmer HG. Tankyrase Inhibition Blocks Wnt/β-Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer. Clin Cancer Res. 2016 Feb 1;22(3):644-56. doi: 10.1158/1078-0432.CCR-14-3081.
  • Ibarrola-Villava M, Fleitas T, Llorca-Cardeñosa MJ, Mongort C, Alonso E, Navarro S, Burgues O, Vivancos A, Cejalvo JM, Perez-Fidalgo JA, Roselló S, Ribas G, Cervantes A. Determination of somatic oncogenic mutations linked to target-based therapies using MassARRAY technology. Oncotarget. 2016 Apr 19;7(16):22543-55. doi: 10.18632/oncotarget.8002.
  • Alves-Rodrigues I, Ferreira PG, Moldón A, Vivancos AP, Hidalgo E, Guigó R, Ayté J. Spatiotemporal Control of Forkhead Binding to DNA Regulates the Meiotic Gene Expression Program. Cell Rep. 2016 Feb 2;14(4):885-95. doi: 10.1016/j.celrep.2015.12.074.
  • Vivancos A, Caratú G, Matito J, Muñoz E, Ferrer B, Hernández-Losa J, Bodet D, Pérez-Alea M, Cortés J, Garcia-Patos V, Recio JA. Genetic evolution of nevus of Ota reveals clonal heterogeneity acquiring BAP1 and TP53 mutations. Pigment Cell Melanoma Res. 2016 Mar;29(2):247-53. doi: 10.1111/pcmr.12452.
  • Yus E, Güell M, Vivancos AP, Chen WH, Lluch-Senar M, Delgado J, Gavin AC, Bork P, Serrano L. Transcription start site associated RNAs in bacteria. Mol. Syst. Biol. 2012; 8: 585
  • Esteve-Codina A, Kofler R, Himmelbauer H, Ferretti L, Vivancos AP, Groenen MA, Folch JM, Rodríguez MC, Pérez-Enciso M. Partial short-read sequencing of a highly inbred Iberian pig and genomics inference thereof. Heredity (Edinb) 2011 Sep; 107(3): 256-64
  • Zuin A, Carmona M, Morales-Ivorra I, Gabrielli N, Vivancos AP, Ayté J, Hidalgo E. Lifespan extension by calorie restriction relies on the Sty1 MAP kinase stress pathway. EMBO J. 2010 Mar; 29(5): 981-91
  • Vivancos AP, Castillo EA, Biteau B, Nicot C, Ayté J, Toledano MB, Hidalgo E. A cysteine-sulfinic acid in peroxiredoxin regulates H2O2-sensing by the antioxidant Pap1 pathway. Proc. Natl. Acad. Sci. U.S.A. 2005 Jun; 102(25): 8875-80
  • Vivancos AP, Castillo EA, Jones N, Ayté J, Hidalgo E. Activation of the redox sensor Pap1 by hydrogen peroxide requires modulation of the intracellular oxidant concentration. Mol. Microbiol. 2004 Jun; 52(5): 1427-35
  • Castillo EA, Vivancos AP, Jones N, Ayté J, Hidalgo E. Schizosaccharomyces pombe cells lacking the Ran-binding protein Hba1 show a multidrug resistance phenotype due to constitutive nuclear accumulation of Pap1. J. Biol. Chem. 2003 Oct; 278(42): 40565-72
  • FUSOMAP: Development of microbiota-based diagnostic and prognostic models by mapping intratumoral Fusobacterium and associated gut microbiota in early-stage colorectal cancer – Mutua Madrileña and ISCIII.
  • Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions – COLOSSUS, H2020.
  • Opportunity: To Investigate the Microbiome’s Impact on Science and Treatment In Colorectal Cancer – OPTIMISTICC, Grand Challenge, Cancer Research UK.
  • Microbiota composition as risk predictor in cancer patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – La Marató TV3, 2021.